Instituto Hermes Pardini S.A., together with its subsidiaries, provides medical, dental, laboratory research, clinical analysis, and supplementary diagnostic and therapeutic services in Brazil. The company offers precision medicine, medical imaging, and unprecedented differentials in the field of forensic toxicology, occupational medicine, and clinical medicine, as well as sample collection services for clinical analysis tests, imaging tests, and vaccines. In addition, it engages in the resale of laboratory test supplies; personalized medicine diagnosis; and pathological anatomy business. The company primarily operates through Hermes Pardini, Padrão, Progenética, Diagnóstika, Cemedi, Centro de Medicina, Ecoar, Labclass Hermes Pardini, DLE, Toxicologia Pardini, Solução, APC, CLINICA DE IMAGEM, and Saúde Mob brand names. It serves hospitals, clinics, laboratories, and other companies in the health care sector. Instituto Hermes Pardini S.A. was founded in 1959 and is based in Belo Horizonte, Brazil.
Show more...
CEO
Mr. Roberto Santoro Meirelles
従業員
7100
国
Brazil
ISIN
BRPARDACNOR1
上場銘柄
0 Comments
意見をシェア
FAQ
Instituto Hermes Pardini SAの株価は今日いくらですか?▼
PARD3.SA の現在価格は R$20.25 BRL で、過去24時間で +0% 上昇しました。チャートで Instituto Hermes Pardini SA 株価の動きを詳しく確認しましょう。